Silexion Therapeutics Ltd.SLXNNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank95
3Y CAGR+2142.1%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
+2142.1%/yr
Quarterly compound
Percentile
P95
Near historical high
vs 3Y Ago
11270.4x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 2874.81% |
| Q2 2025 | -45.72% |
| Q1 2025 | 188.39% |
| Q4 2024 | 38.97% |
| Q3 2024 | 79.60% |
| Q2 2024 | 71.20% |
| Q1 2024 | 3.04% |
| Q4 2023 | -2287.85% |
| Q3 2023 | -85.14% |
| Q2 2023 | 83.71% |
| Q1 2023 | 584.51% |
| Q4 2022 | -106.16% |
| Q3 2022 | 0.26% |
| Q2 2022 | 0.04% |
| Q1 2022 | -0.21% |
| Q4 2021 | -0.21% |
| Q3 2021 | -0.19% |
| Q2 2021 | -0.17% |
| Q1 2021 | 68081.67% |
| Q4 2020 | 0.00% |